Healthcare Services

Gene Delivery Technologies Market Shaped by Advances in Protein Analysis Tools

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Gene Delivery Technologies Market During 2026–2030?

The gene delivery technologies market size has experienced swift expansion in recent years. This market is projected to grow from $4.29 billion in 2025 to $4.92 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.7%. The historical increase in the market can be linked to factors such as the growth in gene therapy research, the development of viral vectors, academic research funding, the application of electroporation techniques, and ongoing vaccine development programs.

The gene delivery technologies market is projected to expand significantly, reaching $8.46 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.5%. This growth in the coming years is attributed to the expansion of gene therapy pipelines, ongoing innovation in delivery vectors, the increasing demand for safer delivery methods, the rise of cell therapy applications, and heightened clinical trial activity. Noteworthy trends during this forecast period include the growing adoption of both viral and non-viral delivery systems, their increased use in gene and cell therapy, the evolution of lipid nanoparticle technologies, a stronger focus on targeted gene delivery, and advancements in physical gene transfer methods.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Which Key Drivers Are Affecting The Gene Delivery Technologies Market Development?

The gene delivery technologies market is expected to experience growth driven by the increasing number of cell and gene therapies. These medical treatments are designed to cure or alleviate diseases by modifying a patient’s genetic and cellular makeup. The surge in cell and gene therapies is primarily fueled by advancements in gene editing technologies, which play a crucial role in their development and commercialization. For instance, in March 2025, IQVIA, a US-based provider of advanced analytics, technology solutions, and contract research services, reported that the volume of new CAR T trial starts reached 199 in 2024, with gene therapy trial starts reaching 130; these figures showed increases of 54% and 65%, respectively. Therefore, the rising prevalence of cell and gene therapies propels the gene delivery technologies market.

What Are The Different Segment Types In The Gene Delivery Technologies Market Segment Breakdown?

The gene delivery technologies market covered in this report is segmented –

1) By Mode: Biological, Chemical, Physical

2) By Method: Ex Vivo, In Vivo, In Vitro

3) By Application: Gene Therapy, Cell Therapy, Vaccines, Research

Subsegments:

1) By Biological: Viral Vectors, Bacterial Vectors, Lipid Nanoparticles

2) By Chemical: Cationic Lipids, Polymers, Chemical Transfection Agents

3) By Physical: Electroporation, Microinjection, Gene Gun, Sonoporation

What Trends Are Transforming The Gene Delivery Technologies Market?

Major companies engaged in gene delivery technologies are concentrating on creating sophisticated products, such as ProteoAnalyzer, to secure a competitive advantage in the market. The ProteoAnalyzer stands as an advanced automated system, conceived by Agilent Technologies, dedicated to protein analysis, specifically leveraging parallel capillary electrophoresis (CE) technology. Illustratively, in July 2024, Agilent Technologies Inc., a US-based life sciences company, unveiled its ProteoAnalyzer system. This innovative platform is engineered for automated parallel capillary electrophoresis (CE), facilitating rapid, high-resolution protein analysis while consuming minimal sample. This capability particularly benefits researchers dealing with intricate protein mixtures within pharmaceuticals, biopharma, and bioengineered food ingredients, thereby accelerating discoveries and advancements in translational research. The system provides for a comprehensive examination of protein mixtures, which is essential for the development of therapeutic proteins.

Who Are The Well-Known Companies In The Gene Delivery Technologies Market?

Major companies operating in the gene delivery technologies market are Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Catalent Inc., Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Beam Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG

Get The Full Gene Delivery Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Which Region Is The Leading Market For The Gene Delivery Technologies Market?

North America was the largest region in the gene delivery technologies market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gene Delivery Technologies Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Browse Through More Reports Similar to the Global Gene Delivery Technologies Market 2026, By The Business Research Company

Advanced Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report

Recombinant Dna Technology Market Report 2026

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795